Pfizer says its antiviral pill cuts risk of severe COVID-19 by 89 percent
A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89 percent the chances of hospitalization or death for…
A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89 percent the chances of hospitalization or death for…